Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #1,051 to #1,100.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Liu B, et al. Am. J. Cancer Res. (2019) cited as Ref 648 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  2. (hist) ‎Chang L, et al. Oncotarget (2016) cited as Ref 647 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  3. (hist) ‎Zhao J, et al. Pharmacol. Ther. (2016) cited as Ref 646 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  4. (hist) ‎Prieto-Vila M, et al. Int. J. Mol. Sci. (2017) cited as Ref 645 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  5. (hist) ‎Rich JN, et al. Medicine (2016) cited as Ref 644 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  6. (hist) ‎Nandy SB, et al. Prog. Mol. Biol. Transl. Sci. (2017) cited as Ref 643 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  7. (hist) ‎Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  8. (hist) ‎Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  9. (hist) ‎Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  10. (hist) ‎Motzer RJ, et al. N. Engl. J. Med. (2019) cited as Ref 639 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  11. (hist) ‎Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  12. (hist) ‎Cortese I, et al. N. Engl. J. Med. (2019) cited as Ref 637 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  13. (hist) ‎Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  14. (hist) ‎Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  15. (hist) ‎Salgia R, et al. Lung Cancer (2017) cited as Ref 634 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  16. (hist) ‎Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  17. (hist) ‎Galsky MD, et al. Clin. Cancer Res. (2014) cited as Ref 632 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  18. (hist) ‎Cooper TM, et al. Pediatr. Blood Cancer (2017) cited as Ref 631 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  19. (hist) ‎Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  20. (hist) ‎Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  21. (hist) ‎Saygin C, et al. Cell Stem Cell (2019) cited as Ref 628 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  22. (hist) ‎Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  23. (hist) ‎Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  24. (hist) ‎Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  25. (hist) ‎Le PN, et al. Pharmacol. Ther. (2015) cited as Ref 624 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  26. (hist) ‎Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  27. (hist) ‎Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  28. (hist) ‎Hua F, et al. Gastroenterology (2019) cited as Ref 621 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  29. (hist) ‎Fu L, et al. Gut (2011) cited as Ref 620 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  30. (hist) ‎Kraggerud SM, et al. Endocr. Rev. (2013) cited as Ref 619 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  31. (hist) ‎Pohl SG, et al. Oncogenesis (2017) cited as Ref 618 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  32. (hist) ‎Lauth M, et al. Proc. Natl Acad. Sci. USA (2007) cited as Ref 617 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  33. (hist) ‎List A, et al. Leukemia (2003) cited as Ref 616 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  34. (hist) ‎Cortes JE, et al. Leukemia (2019) cited as Ref 615 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  35. (hist) ‎Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  36. (hist) ‎Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  37. (hist) ‎Kieran MW, et al. Neuro Oncol. (2017) cited as Ref 612 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  38. (hist) ‎Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  39. (hist) ‎Kaye SB, et al. Clin. Cancer Res. (2012) cited as Ref 610 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  40. (hist) ‎Houot R, et al. Ann. Oncol. (2016) cited as Ref 609 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  41. (hist) ‎Italiano A, et al. Ann. Oncol. (2013) cited as Ref 608 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  42. (hist) ‎Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  43. (hist) ‎Berlin J, et al. Clin. Cancer Res. (2013) cited as Ref 606 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  44. (hist) ‎Gajjar A, et al. Clin. Cancer Res. (2013) cited as Ref 605 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  45. (hist) ‎Robinson GW, et al. J. Clin. Oncol. (2015) cited as Ref 604 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  46. (hist) ‎Zito PM, et al. () cited as Ref 603 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  47. (hist) ‎Scales SJ, et al. Trends Pharmacol. Sci. (2009) cited as Ref 602 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  48. (hist) ‎Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  49. (hist) ‎Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  50. (hist) ‎Sekulic A, et al. N. Engl. J. Med. (2012) cited as Ref 599 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)